Venlafaxine 225 mg/1 (Venlafaxine TABLET, EXTENDED RELEASE) 225 mg/1

Venlafaxine 225 mg extended-release tablets are an antidepressant used to manage mood disorders. This medication is designed for oral use and is manufactured by Ajanta Pharma USA Inc.

Strength

225 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-224-30)

Manufacturer / TM Owner

Ajanta Pharma USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venlafaxine 225 mg extended-release tablets are commonly used to treat depression and anxiety disorders. This medication works by affecting the balance of certain natural substances in the brain, which may help improve mood and reduce anxiety. It is often prescribed for individuals who require long-term management of these conditions.

Side Effects

Common effects of Venlafaxine 225 mg extended-release tablets may include nausea, dizziness, and dry mouth. Some users may also experience changes in appetite or sleep patterns. These effects are generally mild and may diminish as the body adjusts to the medication.

Precautions & Warnings

Venlafaxine 225 mg extended-release tablets should be taken as directed by a healthcare professional. It is important to follow the prescribed dosage and not to abruptly stop taking the medication without consulting a doctor. This medication should be stored at room temperature, away from moisture and heat.

Avoid Interactions

Venlafaxine 225 mg extended-release tablets may interact with other medications, including those that affect serotonin levels. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while taking this medication, as it may increase the risk of side effects.

Frequently Asked Questions

Venlafaxine 225 mg extended-release tablets are used to treat depression and anxiety disorders by balancing natural substances in the brain.

Venlafaxine 225 mg extended-release tablets should be taken orally, usually once daily, with or without food, as directed by your healthcare provider.

Common side effects may include nausea, dizziness, dry mouth, and changes in appetite or sleep patterns.

It is generally advised to avoid alcohol while taking Venlafaxine, as it may increase the risk of side effects.

Venlafaxine tablets should be stored at room temperature, away from moisture and heat, in their original packaging.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.